Benjamin Noll

Comparison of blood sirolimus, tacrolimus and everolimus concentrations measured by LC-MS/MS, HPLC-UV and immunoassay methods

Benedetta C. Sallustio, Benjamin Noll, Raymond G. Morris · Clinical Biochemistry · 2010 · 79 citations

Allergy, Immunology, Blood Sirolimus +2

Highly Potent, Selective, and Orally Bioavailable 4-Thiazol-<i>N</i>-(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug Candidates: Design, Synthesis, and Evaluation

Solomon Tadesse, Mingfeng Yu, Laychiluh Mekonnen et al. · Journal of Medicinal Chemistry · 2017 · 68 citations · Full text

Chemoprevention Strategy, Pharmacotherapy, Cell Cycle +17

Validation of an LC–MS/MS Method to Measure Tacrolimus in Rat Kidney and Liver Tissue and Its Application to Human Kidney Biopsies

Benjamin Noll, Janet K. Coller, Andrew A. Somogyi et al. · Therapeutic Drug Monitoring · 2013 · 34 citations

Discovery and pharmacological evaluation of a novel series of adamantyl cyanoguanidines as P2X7 receptor antagonists

James O’Brien-Brown, Alexander Jackson, Tristan A. Reekie et al. · European Journal of Medicinal Chemistry · 2017 · 32 citations · Full text

Novel Series, Biochemistry, Functional Selectivity +7

Discovery and pharmacological characterization of a novel series of highly selective inhibitors of cyclin‐dependent kinases 4 and 6 as anticancer agents

Solomon Tadesse, Laychiluh Bantie, Khamis Tomusange et al. · British Journal of Pharmacology · 2017 · 26 citations · Full text